Publications

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Jillian Romeo2021-04-27T23:15:39-04:00

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19Jillian Romeo2021-04-27T23:15:39-04:00

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity

Jillian Romeo2021-04-27T23:15:40-04:00

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activityJillian Romeo2021-04-27T23:15:40-04:00

Complement‐activated human endothelial cells stimulate increased polyfunctionality in alloreactive T cells.

[email protected]2021-04-27T23:15:40-04:00

Complement‐activated human endothelial cells stimulate increased polyfunctionality in alloreactive T cells.[email protected]2021-04-27T23:15:40-04:00

Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19.

[email protected]2021-04-27T23:15:41-04:00

Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19.[email protected]2021-04-27T23:15:41-04:00

Progression-free Survival and Biomarker Correlates of Response With BEMPEG Plus NIVO in Previously Untreated Patients With Metastatic Melanoma: Results From The PIVOT-02 Study.

Jillian Romeo2021-04-27T23:15:41-04:00

Progression-free Survival and Biomarker Correlates of Response With BEMPEG Plus NIVO in Previously Untreated Patients With Metastatic Melanoma: Results From The PIVOT-02 Study.Jillian Romeo2021-04-27T23:15:41-04:00

Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer.

[email protected]2021-04-27T23:15:42-04:00

Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer.[email protected]2021-04-27T23:15:42-04:00

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice.

[email protected]2021-04-27T23:15:42-04:00

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice.[email protected]2021-04-27T23:15:42-04:00

Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19.

Jillian Romeo2021-04-27T23:15:43-04:00

Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19.Jillian Romeo2021-04-27T23:15:43-04:00

Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity.

[email protected]2021-04-27T23:15:43-04:00

Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity.[email protected]2021-04-27T23:15:43-04:00

Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line.

[email protected]2021-04-27T23:15:44-04:00

Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line.[email protected]2021-04-27T23:15:44-04:00